ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

MNKD MannKind Corporation

4,23
0,05 (1,20%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
MannKind Corporation MNKD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,05 1,20% 4,23 06:00:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,20 4,15 4,365 4,23 4,18
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.4.202412:00GLOBEMannKind Repays Certain Debt Obligations
26.3.202421:05GLOBEMannKind Announces CFO Transition
11.3.202411:05GLOBEINHALE-3 Study’s Initial Meal Challenge Results Comparing..
05.3.202412:05GLOBEMannKind Announces New Clinical Data From Inhale-3 Study to..
04.3.202419:01GLOBEMannKind Corporation Announces Participation at Upcoming..
27.2.202422:05EDGAR2Form 8-K - Current report
27.2.202422:00GLOBEMannKind Corporation Reports 2023 Fourth Quarter and Full..
20.2.202412:00GLOBEMannKind Corporation to Hold 2023 Fourth Quarter and Full..
15.2.202412:05GLOBEMannKind Announces Enrollment Goal Completion of INHALE-1..
05.2.202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202412:06EDGAR2Form 8-K - Current report
02.1.202412:05GLOBEMannKind and Sagard Healthcare Enter Into Royalty Purchase..
28.12.202312:00GLOBEMannKind Corporation to Present at 42nd Annual J.P. Morgan..
27.12.202322:15EDGAR2Form 8-K - Current report
16.12.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202322:09EDGAR2Form 144 - Report of proposed sale of securities
15.12.202301:56EDGAR2Form 144 - Report of proposed sale of securities
14.12.202322:08EDGAR2Form 144 - Report of proposed sale of securities
07.11.202322:05EDGAR2Form 8-K - Current report
07.11.202322:00GLOBEMannKind Corporation Reports 2023 Third Quarter Financial..
06.11.202312:15GLOBEMannKind Announces Completion of Enrollment in U.S. Phase 4..
03.11.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202300:07EDGAR2Form 144 - Report of proposed sale of securities
31.10.202321:00GLOBEMannKind Corporation to Hold 2023 Third Quarter Financial..
30.10.202311:15GLOBEMannKind Expands Patent Portfolio With New Clofazimine..
04.10.202303:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
03.10.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202323:51EDGAR2Form 144 - Report of proposed sale of securities
06.9.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202312:00GLOBEMannKind Corporation Announces Participation at Upcoming..
01.9.202322:11EDGAR2Form 144 - Report of proposed sale of securities
29.8.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202300:45EDGAR2Form 144 - Report of proposed sale of securities
23.8.202322:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.8.202322:06EDGAR2Form 8-K - Current report
07.8.202322:00GLOBEMannKind Corporation Reports 2023 Second Quarter Financial..
02.8.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202300:30EDGAR2Form 144 - Report of proposed sale of securities
01.8.202312:00GLOBEMannKind Corporation Announces Participation in the 2023..
31.7.202322:00GLOBEMannKind Corporation to Hold 2023 Second Quarter Financial..
05.7.202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.6.202312:05GLOBEMannKind Launches Inhale-3 Study to Address the Most..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock